Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025)
Vertex Pharmaceuticals' quarterly Asset Writedowns and Impairment came in at $379.0 million in Q1 2025, up 4481.5% quarter-over-quarter from -$8.6 million in Q4 2019.
Vertex Pharmaceuticals has reported Asset Writedowns and Impairment for 10 years, with the latest figure at $379.0 million in Q1 2025.
- For the quarter ending Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to $379.0 million; the trailing twelve-month figure through Dec 2025 stood at $379.0 million (changed N/A YoY), and the FY2025 full-year result was $379.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at $379.0 million, up from -$8.6 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $379.0 million in Q1 2025, with the low at $379.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 379.00 Mn |
| Mar 31, 2025 | 379.00 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Dec 31, 2015 | -23,000.00 |
| Dec 31, 2015 | -23,000.00 |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2013 | 250.60 Mn |
| Dec 31, 2013 | 250.60 Mn |
| Mar 31, 2013 | 412.90 Mn |
| Mar 31, 2013 | 412.90 Mn |
| Sep 30, 2011 | 105.80 Mn |
| Sep 30, 2011 | 105.80 Mn |
| Dec 31, 2010 | -624,000.00 |
| Dec 31, 2010 | -624,000.00 |
| Jun 30, 2010 | 24,000.00 |
| Jun 30, 2010 | 24,000.00 |
| Mar 31, 2010 | 600,000.00 |
| Mar 31, 2010 | 600,000.00 |
| Dec 31, 2009 | 7.20 Mn |
| Dec 31, 2009 | 7.20 Mn |
| Jun 30, 2009 | 3.50 Mn |
| Jun 30, 2009 | 3.50 Mn |